Table 3. Logistic regression model of analysed end points by the CBMN assay for: (A) BC vs controls; (B) NMIBC vs controls; (C) MIBC vs controls.

	Coefficients	s.e.	Pa
MN
BC vs controls	0.104	0.029	<0.01
NMIBC vs controls	0.114	0.030	<0.01
MIBC vs controls	0.011	0.069	0.87
NPB
BC vs controls	0.115	0.121	0.34
NMIBC vs controls	0.130	0.125	0.30
MIBC vs controls	−0.016	0.292	0.96
NBUD
BC vs controls	0.132	0.043	<0.01
NMIBC vs controls	0.148	0.045	<0.01
MIBC vs controls	−0.037	0.112	0.74

Abbreviations: BC=bladder cancer; MIBC=muscle-invasive bladder cancer; MN=micronuclei frequencies; NBUD=nuclear buds frequencies; NMIBC=Non-muscle invasive bladder cancer; NPB=nucleoplasmic bridge frequencies; s.e.=standard error.

Significant results in bold.

^aAdjusted for age and smoking.